原标题:大摩指康方生物(09926-HK)药物名单丰富及研发引擎强劲 升目标价至43.5港元 来源:财华社【财华社讯】大摩发布报告指康方生物(09926-HK)药物名单丰富及研发引擎强劲,升其目标价至43.5港元,给予增持评级。该公司股价现报43.2港元,涨0.47%,成交量26.70万,成交额1159.47万港元。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.